Immunic, Inc. (IMUX)
14.01
+1.04
(+8.02%)
USD |
NASDAQ |
May 27, 16:00
14.01
0.00 (0.00%)
After-Hours: 18:38
Immunic Total Liabilities (Quarterly) : 38.51M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 10.83B |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Sarepta Therapeutics, Inc. | 1.674B |
| ImmunityBio, Inc. | 1.516B |
| Mineralys Therapeutics, Inc. | 14.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 189.74M |
| Shareholders Equity (Quarterly) | 151.23M |
| Debt to Equity Ratio | 0.0028 |
| Current Ratio | 4.920 |
| Net Debt Paydown Yield | 0.08% |